Anticitrullinated protein antibodies and rheumatoid factor fluctuate in early inflammatory arthritis and do not predict clinical outcomes Academic Article uri icon

Overview

MeSH Major

  • Antibodies, Anti-Idiotypic
  • Antirheumatic Agents
  • Arthritis, Rheumatoid
  • Peptides, Cyclic
  • Rheumatoid Factor

abstract

  • RF and ACPA have the potential to revert and convert during the early course of disease. Fluctuations in RF and ACPA were not associated with clinical outcomes.

publication date

  • August 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3899/jrheum.120736

PubMed ID

  • 23378461

Additional Document Info

start page

  • 1259

end page

  • 67

volume

  • 40

number

  • 8